14-92071010-C-CTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_004993.6(ATXN3):c.915_916insCAGCAGCAGCAGCAGCA(p.Gly306GlnfsTer31) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.040 ( 177 hom., cov: 20)
Exomes 𝑓: 0.063 ( 3324 hom. )
Failed GnomAD Quality Control
Consequence
ATXN3
NM_004993.6 frameshift
NM_004993.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.168
Genes affected
ATXN3 (HGNC:7106): (ataxin 3) Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 12-44 to 52-86 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0566 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0404 AC: 5757AN: 142366Hom.: 178 Cov.: 20
GnomAD3 genomes
AF:
AC:
5757
AN:
142366
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0633 AC: 82473AN: 1302292Hom.: 3324 Cov.: 92 AF XY: 0.0625 AC XY: 40704AN XY: 651070
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
82473
AN:
1302292
Hom.:
Cov.:
92
AF XY:
AC XY:
40704
AN XY:
651070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0404 AC: 5753AN: 142476Hom.: 177 Cov.: 20 AF XY: 0.0386 AC XY: 2672AN XY: 69216
GnomAD4 genome
AF:
AC:
5753
AN:
142476
Hom.:
Cov.:
20
AF XY:
AC XY:
2672
AN XY:
69216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at